Literature DB >> 31332078

Environment Shapes the Accessible Daptomycin Resistance Mechanisms in Enterococcus faecium.

Amy G Prater1, Heer H Mehta1, Abigael J Kosgei1, William R Miller2,3, Truc T Tran2,3, Cesar A Arias2,3,4,5,6, Yousif Shamoo7.   

Abstract

Daptomycin binds to bacterial cell membranes and disrupts essential cell envelope processes, leading to cell death. Bacteria respond to daptomycin by altering their cell envelopes to either decrease antibiotic binding to the membrane or by diverting binding away from septal targets. In Enterococcus faecalis, daptomycin resistance is typically coordinated by the three-component cell envelope stress response system, LiaFSR. Here, studying a clinical strain of multidrug-resistant Enterococcus faecium containing alleles associated with activation of the LiaFSR signaling pathway, we found that specific environments selected for different evolutionary trajectories, leading to high-level daptomycin resistance. Planktonic environments favored pathways that increased cell surface charge via yvcRS upregulation of dltABCD and mprF, causing a reduction in daptomycin binding. Alternatively, environments favoring complex structured communities, including biofilms, evolved both diversion and repulsion strategies via divIVA and oatA mutations, respectively. Both environments subsequently converged on cardiolipin synthase (cls) mutations, suggesting the importance of membrane modification across strategies. Our findings indicate that E. faecium can evolve diverse evolutionary trajectories to daptomycin resistance that are shaped by the environment to produce a combination of resistance strategies. The accessibility of multiple and different biochemical pathways simultaneously suggests that the outcome of daptomycin exposure results in a polymorphic population of resistant phenotypes, making E. faecium a recalcitrant nosocomial pathogen.
Copyright © 2019 American Society for Microbiology.

Entities:  

Keywords:  Enterococcuszzm321990; adaptive resistance; drug resistance evolution

Mesh:

Substances:

Year:  2019        PMID: 31332078      PMCID: PMC6761497          DOI: 10.1128/AAC.00790-19

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  61 in total

1.  Peptidoglycan Modification by the Catalytic Domain of Streptococcus pneumoniae OatA Follows a Ping-Pong Bi-Bi Mechanism of Action.

Authors:  David Sychantha; Anthony J Clarke
Journal:  Biochemistry       Date:  2018-04-05       Impact factor: 3.162

2.  Pathogenic Nocardia cyriacigeorgica and Nocardia nova Evolve To Resist Trimethoprim-Sulfamethoxazole by both Expected and Unexpected Pathways.

Authors:  H Mehta; J Weng; A Prater; R A L Elworth; X Han; Y Shamoo
Journal:  Antimicrob Agents Chemother       Date:  2018-06-26       Impact factor: 5.191

3.  Daptomycin resistance mechanisms in clinically derived Staphylococcus aureus strains assessed by a combined transcriptomics and proteomics approach.

Authors:  Adrien Fischer; Soo-Jin Yang; Arnold S Bayer; Ali R Vaezzadeh; Sébastien Herzig; Ludwig Stenz; Myriam Girard; George Sakoulas; Alexander Scherl; Michael R Yeaman; Richard A Proctor; Jacques Schrenzel; Patrice François
Journal:  J Antimicrob Chemother       Date:  2011-05-28       Impact factor: 5.790

4.  Anatomy of the bacitracin resistance network in Bacillus subtilis.

Authors:  Jara Radeck; Susanne Gebhard; Peter Shevlin Orchard; Marion Kirchner; Stephanie Bauer; Thorsten Mascher; Georg Fritz
Journal:  Mol Microbiol       Date:  2016-03-10       Impact factor: 3.501

5.  Enhanced expression of dltABCD is associated with the development of daptomycin nonsusceptibility in a clinical endocarditis isolate of Staphylococcus aureus.

Authors:  Soo-Jin Yang; Barry N Kreiswirth; George Sakoulas; Michael R Yeaman; Yan Q Xiong; Ayumi Sawa; Arnold S Bayer
Journal:  J Infect Dis       Date:  2009-12-15       Impact factor: 5.226

6.  Evaluation of ceftaroline, vancomycin, daptomycin, or ceftaroline plus daptomycin against daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureus in an in vitro pharmacokinetic/pharmacodynamic model of simulated endocardial vegetations.

Authors:  Brian J Werth; Katie E Barber; Cortney E Ireland; Michael J Rybak
Journal:  Antimicrob Agents Chemother       Date:  2014-03-24       Impact factor: 5.191

7.  Binding of Daptomycin to Anionic Lipid Vesicles Is Reduced in the Presence of Lysyl-Phosphatidylglycerol.

Authors:  Tala O Khatib; Heather Stevenson; Michael R Yeaman; Arnold S Bayer; Antje Pokorny
Journal:  Antimicrob Agents Chemother       Date:  2016-07-22       Impact factor: 5.191

8.  Whole genome characterization of the mechanisms of daptomycin resistance in clinical and laboratory derived isolates of Staphylococcus aureus.

Authors:  Anton Y Peleg; Spiros Miyakis; Doyle V Ward; Ashlee M Earl; Aileen Rubio; David R Cameron; Satish Pillai; Robert C Moellering; George M Eliopoulos
Journal:  PLoS One       Date:  2012-01-06       Impact factor: 3.240

9.  The bacterial defensin resistance protein MprF consists of separable domains for lipid lysinylation and antimicrobial peptide repulsion.

Authors:  Christoph M Ernst; Petra Staubitz; Nagendra N Mishra; Soo-Jin Yang; Gabriele Hornig; Hubert Kalbacher; Arnold S Bayer; Dirk Kraus; Andreas Peschel
Journal:  PLoS Pathog       Date:  2009-11-13       Impact factor: 6.823

Review 10.  Intrinsic and acquired resistance mechanisms in enterococcus.

Authors:  Brian L Hollenbeck; Louis B Rice
Journal:  Virulence       Date:  2012-08-15       Impact factor: 5.882

View more
  11 in total

1.  Tedizolid as Step-Down Therapy following Daptomycin versus Continuation of Daptomycin against Enterococci and Methicillin- and Vancomycin-Resistant Staphylococcus aureus in a Rat Endocarditis Model.

Authors:  Kavindra V Singh; Cesar A Arias; Barbara E Murray
Journal:  Antimicrob Agents Chemother       Date:  2020-04-21       Impact factor: 5.191

2.  Evolution of Enterococcus faecium in Response to a Combination of Daptomycin and Fosfomycin Reveals Distinct and Diverse Adaptive Strategies.

Authors:  Adeline Supandy; Heer H Mehta; Truc T Tran; William R Miller; Rutan Zhang; Libin Xu; Cesar A Arias; Yousif Shamoo
Journal:  Antimicrob Agents Chemother       Date:  2022-05-11       Impact factor: 5.938

3.  Nationwide Surveillance on Antimicrobial Resistance Profiles of Enterococcus faecium and Enterococcus faecalis Isolated from Healthy Food Animals in South Korea, 2010 to 2019.

Authors:  Mi Hyun Kim; Dong Chan Moon; Su-Jeong Kim; Abraham Fikru Mechesso; Hyun-Ju Song; Hee Young Kang; Ji-Hyun Choi; Soon-Seek Yoon; Suk-Kyung Lim
Journal:  Microorganisms       Date:  2021-04-26

4.  Sentinel Surveillance Reveals Emerging Daptomycin-Resistant ST736 Enterococcus faecium and Multiple Mechanisms of Linezolid Resistance in Enterococci in the United States.

Authors:  Amy S Gargis; Lori M Spicer; Alyssa G Kent; Wenming Zhu; Davina Campbell; Gillian McAllister; Thomas O Ewing; Valerie Albrecht; Valerie A Stevens; Mili Sheth; Jasmine Padilla; Dhwani Batra; J Kristie Johnson; Alison Laufer Halpin; J Kamile Rasheed; Christopher A Elkins; Maria Karlsson; Joseph D Lutgring
Journal:  Front Microbiol       Date:  2022-02-01       Impact factor: 5.640

5.  Acquisition of Daptomycin Resistance by Enterococcus faecium Confers Collateral Sensitivity to Glycopeptides.

Authors:  Weiliang Zeng; Luozhu Feng; Changrui Qian; Tao Chen; Sipei Wang; Ying Zhang; Xiangkuo Zheng; Lingbo Wang; Shixing Liu; Tieli Zhou; Yao Sun
Journal:  Front Microbiol       Date:  2022-04-12       Impact factor: 5.640

6.  New Mutations in cls Lead to Daptomycin Resistance in a Clinical Vancomycin- and Daptomycin-Resistant Enterococcus faecium Strain.

Authors:  Weiwei Li; Jiamin Hu; Ling Li; Mengge Zhang; Qingyu Cui; Yanan Ma; Hainan Su; Xuhua Zhang; Hai Xu; Mingyu Wang
Journal:  Front Microbiol       Date:  2022-06-21       Impact factor: 6.064

7.  Evolution of vancomycin-resistant Enterococcus faecium during colonization and infection in immunocompromised pediatric patients.

Authors:  Gayatri Shankar Chilambi; Hayley R Nordstrom; Daniel R Evans; Jose A Ferrolino; Randall T Hayden; Gabriela M Marón; Anh N Vo; Michael S Gilmore; Joshua Wolf; Jason W Rosch; Daria Van Tyne
Journal:  Proc Natl Acad Sci U S A       Date:  2020-05-11       Impact factor: 11.205

8.  Systematic Investigation of Resistance Evolution to Common Antibiotics Reveals Conserved Collateral Responses across Common Human Pathogens.

Authors:  Mari C Rodriguez de Evgrafov; Marius Faza; Konstantinos Asimakopoulos; Morten O A Sommer
Journal:  Antimicrob Agents Chemother       Date:  2020-12-16       Impact factor: 5.191

Review 9.  Polymyxin and lipopeptide antibiotics: membrane-targeting drugs of last resort.

Authors:  Elizabeth V K Ledger; Akshay Sabnis; Andrew M Edwards
Journal:  Microbiology (Reading)       Date:  2022-02       Impact factor: 2.777

10.  Mechanistic Insights Into the Differential Efficacy of Daptomycin Plus β-Lactam Combinations Against Daptomycin-Resistant Enterococcus faecium.

Authors:  Razieh Kebriaei; Kyle C Stamper; Kavindra V Singh; Ayesha Khan; Seth A Rice; An Q Dinh; Truc T Tran; Barbara E Murray; Cesar A Arias; Michael J Rybak
Journal:  J Infect Dis       Date:  2020-10-01       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.